Brief: Botanix Pharmaceuticals Posts FY Loss After Income Tax A$13.3 Million
31/08/2022 02:32
Aug 31 (Reuters) - Botanix Pharmaceuticals BOT.AX :
* FY LOSS AFTER INCOME TAX A$13.3 MILLION VERSUS LOSS OF
A$3.3
MILLION
* FY REVENUE FROM CONTINUING OPERATION A$37.4 MILLION VERSUS
A$103.8 MILLION
Source text for Eikon: ID:nASX5Bth5p
Further company coverage: BOT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million